Characteristics of study participants.
| Characteristics | No. (%), n = 45 |
|---|---|
| Male sex | 38 (84) |
| Specialty | |
| Cardiology | 7 (16) |
| Pulmonology | 20 (44) |
| Rheumatology | 17 (38) |
| Internal medicine | 1 (2) |
| No. years seeing patients with pulmonary arterial hypertension (PAH), median (25%–75%) | 15 (10–25) |
| Type of practice (%) | |
| Nonteaching hospital | 0 (0) |
| Teaching hospital | 44 (98) |
| Both | 1 (2) |
| No. new SSc-PAH and/or IPAH patients per year, median (25%–75%) | 30 (15–50) |
| Location of practice | |
| Europe | 8 (18) |
| North America | 37 (82) |
| History of postsecondary statistical training | 27 (60) |
| Use of warfarin in their patients with pulmonary hypertension | 38 (84) |
SSc: systemic sclerosis; IPAH: idiopathic pulmonary arterial hypertension.